Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SGMT Sagimet Biosciences Inc.

盘前交易 08-20 06:26:49 EDT

10.58

+0.00

0.00%

盘前10.55

-0.03-0.28%

05:47 EDT

最高11.03	最低10.49	成交量155.20万
今开10.80	昨收10.58	日振幅5.10%
总市值6.58亿	流通市值6.27亿	总股本6,216万
成交额1,666万	换手率2.62%	流通股本5,924万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":10.58,"timestamp":1787169600000,"preClose":10.58,"halted":0,"volume":1552035,"hourTrading":{"tag":"盘前","latestPrice":10.55,"preClose":10.58,"latestTime":"05:47 EDT","volume":638,"amount":6726.96035,"timestamp":1787219246867,"change":-0.03,"changeRate":-0.002836,"amplitude":0.014178},"delay":0,"changeRate":0,"floatShares":59241840,"shares":62158653,"eps":-1.248952,"marketStatus":"盘前交易","change":0,"latestTime":"08-20 06:26:49 EDT","open":10.8,"high":11.03,"low":10.49,"amount":16659681.821115002,"amplitude":0.05104,"askPrice":10.55,"askSize":700,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.248952,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787232600000},"marketStatusCode":1,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":10.58,"preHourTrading":{"tag":"盘前","latestPrice":10.55,"preClose":10.58,"latestTime":"05:47 EDT","volume":638,"amount":6726.96035,"timestamp":1787219246867,"change":-0.03,"changeRate":-0.002836,"amplitude":0.014178},"postHourTrading":{"tag":"盘后","latestPrice":10.58,"preClose":10.58,"latestTime":"19:30 EDT","volume":9978,"amount":105551.6512,"timestamp":1787182207902,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0328425889786932,"impliedVol":1.0068,"impliedVolPercentile":0.236},"requestUrl":"/m/hq/s/SGMT","defaultTab":"news","newsList":[{"id":"1148899538","title":"Sagimet Biosciences获FDA批准函及IND许可，青少年及成人痤疮III期临床试验正式启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1148899538","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148899538?lang=zh_cn&edition=full","pubTime":"2026-08-13 19:01","pubTimestamp":1786618881,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc. 近日宣布，已收到美国食品药品监督管理局（FDA）的“研究可继续进行”函件，并获得了新药临床试验（IND）许可。这标志着该公司针对青少年及成人痤疮的III期临床试验，已获准正式启动。这一进展，无疑为这家生物科技公司的研发管线注入了强心剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157932668","title":"英国MHRA批准Resmetirom（Rezdiffra）用于治疗成人代谢功能障碍相关脂肪性肝炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1157932668","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157932668?lang=zh_cn&edition=full","pubTime":"2026-06-03 23:30","pubTimestamp":1780500616,"startTime":"0","endTime":"0","summary":"英国药品和健康产品管理局已批准Resmetirom（商品名Rezdiffra）用于治疗成人代谢功能障碍相关脂肪性肝炎。这一决定为MASH患者提供了一种新的治疗选择。该药物的获批基于其临床试验中展现出的疗效与安全性数据。MASH是一种严重的肝脏疾病，与代谢功能障碍密切相关，可导致肝纤维化、肝硬化甚至肝癌。新疗法的问世，有望满足该领域长期存在的未满足医疗需求，改善患者临床结局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162701772","title":"Sagimet Biosciences公布2025年第四季度及全年财务业绩并更新公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1162701772","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162701772?lang=zh_cn&edition=full","pubTime":"2026-03-11 19:31","pubTimestamp":1773228673,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc.近日披露了其2025财年第四季度及全年的财务报告。公司同时就当前运营状况与未来发展策略向市场提供了最新信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614060760","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614060760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614060760?lang=zh_cn&edition=full","pubTime":"2026-02-27 01:16","pubTimestamp":1772126216,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日01时16分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速下挫5.06%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为2.28%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227011656a7233f78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227011656a7233f78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518716122","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.03%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518716122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518716122?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:36","pubTimestamp":1741617379,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时36分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速下挫5.03%。截至发稿，该股报3.50美元/股，成交量12.7763万股，换手率0.40%，振幅6.39%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.02%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022362096404608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022362096404608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516668736","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘股价大跌5.25%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516668736?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:14","pubTimestamp":1741032869,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时14分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下跌5.25%。截至发稿，该股报3.52美元/股，成交量36.6198万股，换手率1.14%，振幅6.94%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.04%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041429989a5bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041429989a5bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514041389","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514041389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:15","pubTimestamp":1740669353,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时15分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升5.21%。截至发稿，该股报4.04美元/股，成交量8.3992万股，换手率0.26%，振幅3.69%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.99%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231553989519d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231553989519d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720995","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.55%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720995?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409502,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下挫5.55%。截至发稿，该股报3.89美元/股，成交量15.5735万股，换手率0.48%，振幅6.31%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.45%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230502a2521cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230502a2521cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512193878","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512193878?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:53","pubTimestamp":1739901213,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时53分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅跳水5.18%。截至发稿，该股报4.03美元/股，成交量52.0051万股，换手率1.62%，振幅10.12%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.66%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015333a24ad74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015333a24ad74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510331586","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速上涨5.03%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510331586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510331586?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:12","pubTimestamp":1739290352,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时12分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速拉升5.03%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为1.57%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212001232abcb1c75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212001232abcb1c75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510286463","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510286463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510286463?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:49","pubTimestamp":1739202548,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时49分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下跌5.25%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.10%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234908961e0fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234908961e0fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509270886","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.85%报4.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509270886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509270886?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:40","pubTimestamp":1738852840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时40分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅跳水5.85%。截至发稿，该股报4.83美元/股，成交量10.2531万股，换手率0.32%，振幅6.24%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.20%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224040abc4d6f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224040abc4d6f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509690424","title":"Sagimet Biosciences Inc. - Series A盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509690424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509690424?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:43","pubTimestamp":1738687411,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时43分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅上涨5.15%。截至发稿，该股报4.90美元/股，成交量20.4621万股，换手率0.64%，振幅6.12%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为1.63%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205004331abc24142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205004331abc24142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508140826","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.20%报4.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508140826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508140826?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:22","pubTimestamp":1738596153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时22分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速上涨5.20%。截至发稿，该股报4.63美元/股，成交量19.9181万股，换手率0.62%，振幅10.21%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为1.19%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203232233a238147a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203232233a238147a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508981309","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508981309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508981309?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:16","pubTimestamp":1738343787,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时16分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速拉升5.38%。截至发稿，该股报4.28美元/股，成交量14.8591万股，换手率0.46%，振幅5.67%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为1.62%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201011628abbe585d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201011628abbe585d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507963205","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.10%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507963205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507963205?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:08","pubTimestamp":1738163304,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日23时08分，Sagimet Biosciences Inc. - Series A股票出现异动，股价急速拉升5.10%。截至发稿，该股报4.53美元/股，成交量12.5156万股，换手率0.39%，振幅5.34%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.56%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129230824a2336de6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129230824a2336de6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506510994","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.63%报4.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506510994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506510994?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:32","pubTimestamp":1738074762,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时32分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下挫5.63%。截至发稿，该股报4.36美元/股，成交量2.8613万股，换手率0.09%，振幅4.33%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.10%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223242a2326f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223242a2326f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506034883","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速上涨5.28%报4.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506034883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506034883?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988343,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅上涨5.28%。截至发稿，该股报4.42美元/股，成交量8.1942万股，换手率0.25%，振幅3.25%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.02%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722322496123970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722322496123970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506372652","title":"Sagimet Biosciences(SGMT.US)获Jones Trading首次覆盖，给予买入评级, 目标价42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506372652","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506372652?lang=zh_cn&edition=full","pubTime":"2025-01-27 21:26","pubTimestamp":1737984401,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences(SGMT.US)获Jones Trading首次覆盖，给予买入评级, 目标价42.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/27212647862183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505260547","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505260547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505260547?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:38","pubTimestamp":1737556682,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时38分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速跳水5.49%。截至发稿，该股报3.90美元/股，成交量8.1373万股，换手率0.25%，振幅4.36%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.05%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223802abb4a77f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223802abb4a77f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagimet.com","stockEarnings":[{"period":"1week","weight":0.1267},{"period":"1month","weight":0.4777},{"period":"3month","weight":0.5114},{"period":"6month","weight":0.9887},{"period":"1year","weight":0.5311},{"period":"ytd","weight":0.7872}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sagimet Biosciences Inc.于2006年12月19日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，开发针对代谢和纤维化通路的新型脂肪酸合成酶抑制剂。其主要候选药物denifanstat是一种口服选择性FASN抑制剂，正在开发用于治疗代谢功能障碍相关脂肪性肝炎、痤疮和某些癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.228208},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.167334},{"month":3,"riseRate":0,"avgChangeRate":-0.107746},{"month":4,"riseRate":0.666667,"avgChangeRate":0.104894},{"month":5,"riseRate":0.666667,"avgChangeRate":0.101166},{"month":6,"riseRate":0.666667,"avgChangeRate":0.282829},{"month":7,"riseRate":0.333333,"avgChangeRate":0.014223},{"month":8,"riseRate":0.25,"avgChangeRate":0.006573},{"month":9,"riseRate":0,"avgChangeRate":-0.152908},{"month":10,"riseRate":0.666667,"avgChangeRate":0.172366},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.001337},{"month":12,"riseRate":0.333333,"avgChangeRate":0.009885}],"exchange":"NASDAQ","name":"Sagimet Biosciences Inc.","nameEN":"Sagimet Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sagimet Biosciences Inc.,SGMT,Sagimet Biosciences Inc.股票,Sagimet Biosciences Inc.股票老虎,Sagimet Biosciences Inc.股票老虎国际,Sagimet Biosciences Inc.行情,Sagimet Biosciences Inc.股票行情,Sagimet Biosciences Inc.股价,Sagimet Biosciences Inc.股市,Sagimet Biosciences Inc.股票价格,Sagimet Biosciences Inc.股票交易,Sagimet Biosciences Inc.股票购买,Sagimet Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}